Aethlon Medical Inc (AEMD): Market Cap to Revenue

Symbol and logo of brand Aethlon Medical Inc (AEMD)

The growth of Aethlon Medical (AEMD) is fundamentally driven by macro resilience and dependence on the FDA rather than the broader economy. This P/S ratio chart from GURU.Markets confirms this, with the current parameter standing at 9.60. Management is leading development by implementing the Hemopurifier to combat infections. A stable moat is provided by a unique exosome filter and stringent regulatory barriers within the medtech sector.

AEMD Aethlon Medical Inc P/S Multiple (07/04/2022 - 06/28/2024)

Analytical breakdowns for Aethlon (AEMD)

- share price and consensus valuation forecast:
Price Performance Chart aethlonmedical.com|AEMD - Price Target Chart
- stock exchange capitalization data:
Market Valuation Aethlon|AEMD - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Aethlon Medical|AEMD - Book Capitalization|Capitalization to Book Value Ratio aethlonmedical.com|AEMD - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Aethlon Medical|AEMD - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Aethlon Medical Corp|AEMD - Company Aggregate Debts|Debts to Book Capitalization Aethlon|AEMD - Company Long-Term Debt|Company Short-Term Debt Aethlon Medical|Intermediate Coverage Ratio aethlonmedical.com
- earnings and multiples data:
AEMD - Net Profit|Expected Net Profit Aethlon Medical|AEMD - Price to Earnings Ratio|Forward Price to Earnings Multiple Aethlon Medical Inc|AEMD - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Aethlon|AEMD - Operating profit EBITDA|Net earnings per share for the last four quarters Aethlon Medical|AEMD - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months aethlonmedical.com|AEMD - Earnings per share growth in current year|Expected earnings per share growth for next year Aethlon Medical
- issuer revenue and sales details:
AEMD - Revenue and Sales Volume|Company Expected Sales Volume aethlonmedical.com|AEMD - Price-to-Revenue Ratio|Market Cap to Projected Revenue Aethlon
General company analysis:AEMD aethlonmedical.com
Core merchandise of Aethlon Medical

High patent barriers and FDA compliance for Aethlon Medical (AEMD) hemosorption cartridges create unique market value, which the current P/S ratio aligns with actual sales volume. This multiple, by dividing market capitalization by annual revenue, allows an investor to determine a fair valuation range for the asset and identify the risk of a fundamental loss of position should the indicator remain at historical lows for a prolonged period.

Competitors of Aethlon Medical

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Price-to-Revenue Multiple|EDAP TMS - Market Cap to Revenue|P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio CTSO (CytoSorbents Corporation)|Price-to-Revenue Ratio Sensus Healthcare Corp|Market Cap to Revenue Zynex Corp (ZYXI)|P/S Multiple ECOR|RBOT - Price to Sales|Price-to-Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Revenue Ratio|IRIX: Market Cap to Revenue|Intelligent Bio Solutions - Market Cap to Sales Volume|XAIR: P/S Multiple|profusa.com (PFSA) - P/S Multiple|SSKN (STRATA Skin Sciences Inc.) - P/S Multiple|Price to Sales glucotrack.com GCTK|Market Cap to Revenue NAOV (NanoVibronix)|Market Cap to Sales Volume VERO|P/S Multiple NUWE (Nuwellis, Inc.)|Market Capitalization-to-Revenue Ratio ASXC|AVGR - Price-to-Revenue Ratio|BSGM: Price-to-Revenue Ratio|Cutera, Inc (CUTR) - Price-to-Revenue Ratio|Price to Sales Know Labs Corporation (KNW)|Price-to-Revenue Ratio Inari Medical, Inc.|Market Cap to Revenue Ratio NVRO (nevro.com)|Market Cap to Revenue RSLS (ReShape Lifesciences)|SILK (Silk Road Medical, Inc.) - Market Capitalization-to-Revenue Ratio